Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can VR games restore lost vision in young brain tumor survivors?

NCT ID NCT07558395

Symptom relief Sponsor: Institut National de la Santé Et de la Recherche Médicale, France Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Sep 17, 2026 · Updated 2 times

Summary

This study tests whether a virtual reality program can improve vision in 120 children, teens, and young adults who have lost part of their visual field (hemianopsia) after a brain tumor. Participants will use a VR headset at home for 8 weeks to do visual exercises. The goal is to see if this can help them see more in their blind area and improve their daily life.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
virtual reality visual stimulation program (3D-MOT)
What this could lead to
If it works, this could offer a home-based way to improve visual field loss and quality of life for young brain tumor survivors.
What could go wrong
This is an early-stage trial with no prior results, so the program may not improve vision. The effect may also vary from person to person.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 120 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Dec 2026

An estimate. Start dates often move.

Expected to finish

Dec 2026

An estimate. End dates often move.

Lead sponsor

A government agency

The lead sponsor is a government body.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

10 to 40 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Male and Female * 10 - 40 years old * Diagnosed hemianopsia (\>12 months) * History of diagnosis brain tumour * Being stable for the tumour for \> 6 months (either on therapy or not) * Visual acuity ≤ 0.7 LogMAR * Ability to follow the visual and auditory stimuli and training instructions * Home WiFi access * Ability to attend all on site visits * Affiliation to the Social Security or beneficiary of such social protection Exclusion Criteria: * Age\< 10 years old of \> 40 years old * Ocular disease * Inability to perform during testing or training * 3 consecutive VRISE scores \< 25 at inclusion * History of vertigo * Prior vision rehabilitation interventions * Recreational or medicinal consumption of psychoactive drugs * Persons under court protection * Interpupillary distance \< 54mm

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Hemianopsia are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

brain cancer Hemianopsia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Hemianopsia Pediatric brain tumor Virtual reality Visual rehabilitation

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    8 sites in 7 countries. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Department of Paediatric and adolescents medicine, Medical University

    Vienna, Austria

  • Great Ormond Street Hospital for Children

    London, United Kingdom

  • Hôpital de Hautepierre

    Strasbourg, France

  • Institute of Tumour, department of haematology and Oncohaematology paediatric

    Milan, Italy

  • Paediatric Haematology, University Hospital

    Padova, Italy

  • Paediatric Oncology, San Joan de Deu

    Barcelona, Spain

  • Paediatrics and Adolescents Medicine, University Hospital

    Copenhagen, Denmark

  • Princess Maxima Centre for Paediatric Oncology

    Utrecht, Netherlands

More trials for these conditions

Other studies related to the condition(s) this trial covers.